Evogene (NASDAQ:EVGN) Earns Sell Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Evogene Price Performance NASDAQ:EVGN opened at $1.55 on Friday. The firm’s fifty day moving average price is $1.57 and its 200 day moving […]
